It was proposed that PCSK2 can cleave and activate MMP-25, which can result in the breakdown of myelin similar to what is seen in autoimmune and inflammatory processes in MS (Shiryaev et al., 2009). This evidence concerns the gene MMP25 and myeloid sarcoma.